---
run_id: halo-evidence-vs-diagnosis-validation-v11-famous-sources-supplied-06
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: famous_sources_supplied
run_number: 6
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 602
prompt_source: condition packet (famous_sources_supplied) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: a name-level list of famous source titles and authors, then the frozen Advisor prompt; no claims, summaries, source cards, or tension card - see run-packet.md
source_packet_sha256: 5f0d18f3e982d60319cdf56d83f5bfcb60ca486dc8eccd9dfcda42bea551750c
condition_packet_sha256: 5f0d18f3e982d60319cdf56d83f5bfcb60ca486dc8eccd9dfcda42bea551750c
output_file: model-outputs/famous_sources_supplied-06.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - famous_sources_supplied (run 06)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `famous_sources_supplied`, run 6 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 602, on the frozen condition packet.

## Output

**Recommendation:** Run the Claim File Review.

**Why:** Your current success is "entangled," meaning your lagging indicators (bookings, renewals) are likely being driven by sales incentives (bundle pricing) and executive optimism rather than product-market fit. The usage data is equally deceptive: high volume is driven by managers (non-users) and initial novelty, while the core user (the adjuster) is abandoning the tool due to a fundamental "explainability" gap in regulated segments.

The Usage Quality Sprint measures *if* they use it, and the Commercial Cleanroom measures *if* they will pay for it, but neither explains *why* the product is failing the adjuster's workflow. Before scaling or narrowing the market, you must determine if SignalPath is providing actual utility (accepted suggestions) or merely "noise" that managers find useful for reporting. The Claim File Review is the only option that audits the actual work product to distinguish between a "sold" feature and a "solved" problem.

**Strongest Reason Against:** This is the slowest, most manual path to an answer. Unlike a dashboard (Sprint) or a sales test (Cleanroom), this requires qualitative labor and manual auditing of files. In a twelve-day window to lock the budget, this approach provides the least "immediate" data for a board presentation and risks being viewed as too academic compared to hard revenue metrics.

**Evidence that would change my mind:** If the "Commercial Cleanroom" results were to show that customers are renewing and expanding at the same rate *without* the SignalPath pitch or bundle pricing. That would indicate that the company's overall value proposition is so strong that SignalPath’s specific utility is secondary to the platform's general existence, making a deep-dive file review an unnecessary distraction from broader scaling.
